PAVM stock news · PAVmed

Stories about PAVmed (PAVM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PAVM

Follow PAVmed (PAVM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 23, 2026, 8:20 AM ET · Market
12 health care companies are changing a lot in Friday's early trading.
Neutral
PAVmed's shares rose about 10% to $2.25 in Friday's pre-market session. The report gives no company update, so the move alone does not change PAVmed's business outlook.
Oct 1, 2026, 1:15 PM ET · Market
On Thursday, 12 health care stocks saw big price changes, with Nexalin Technology jumping up 77.8%.
Neutral
PAVmed shares fell 25.48% during Thursday's session, but the article gives no company news explaining the drop, so its business outlook is unchanged.
Aug 14, 2026, 10:51 AM ET · Market
PAVmed Inc. reveals operational outcomes and financial status (PAVM).
Neutral
PAVmed Inc. has disclosed its results of operations and financial condition through a Form 8-K filing, which is essential for stakeholders to assess the company's current performance and future outlook. This information could influence trading decisions as investors analyze the details.
Aug 14, 2026, 9:11 AM ET · Results
Transcript of PAVmed's Earnings Call for Q2 2026 Now Available.
Good for PAVM
PAVmed's Q2 earnings call revealed a significant reduction in net loss compared to the previous year, alongside updates on regulatory pathways and commercialization efforts for its products. The company's financial improvements and strategic initiatives may enhance investor confidence and drive stock performance.